CSIMarket


Oramed Pharmaceuticals Inc   (ORMP)
Other Ticker:  
 

Oramed Pharmaceuticals Inc

ORMP's Fundamental analysis








Oramed Pharmaceuticals Inc 's sales fell in III. Quarter 2023 from the same quarter a year ago. Ranking at No. 1824

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -4.74 %

Oramed Pharmaceuticals Inc 's net profit deacreased by -70.33 % in III. Quarter 2023 year on year, to $3 millions.

More on ORMP's Growth


Oramed Pharmaceuticals Inc
current PE on trailing twelve month basis is below Major Pharmaceutical Preparations industry average.

Oramed Pharmaceuticals Inc realized cash outflow of $ -0.78per share in trailing twelve-month period.
Company
6.3
PE TTM   
Industry
364.94
PE TTM    
Company's Price to Sales ratio is at 46.61.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.4.


More on ORMP's Valuation
 
 Total Debt (Millions $) 75
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ 736,238
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 3.66

Oramed Pharmaceuticals Inc
current PE on trailing twelve month basis is below Major Pharmaceutical Preparations industry average.

Oramed Pharmaceuticals Inc realized cash outflow of $ -0.78per share in trailing twelve-month period.
Company
6.3
PE TTM   
Industry
364.94
PE TTM    
Company's Price to Sales ratio is at 46.61.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.4.

Oramed Pharmaceuticals Inc Price to Book Ratio is at 0.64 lower than Indusry Avg. of 1539.63. and higher than S&P 500 Avg. of 0.01

More on ORMP's Valuation

  Market Capitalization (Millions $) 94
  Shares Outstanding (Millions) 40
  Employees 21
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) 15
  Cash Flow (TTM) (Millions $) -32
  Capital Exp. (TTM) (Millions $) 0
  Total Debt (Millions $) 75
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ 736,238
  Receivable Turnover Ratio (TTM) -
  Tangible Book Value (Per Share $) 3.66

  Market Capitalization (Millions $) 94
  Shares Outstanding (Millions) 40
  Employees 21
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) 15
  Cash Flow (TTM) (Millions $) -32
  Capital Exp. (TTM) (Millions $) 0





  Ratio
   Capital Ratio (MRQ) 2.25
  Total Debt to Equity (MRQ) 0.51
  Tangible Leverage Ratio (MRQ) 0.55
  Asset Turnover Ratio (TTM) -
  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com